Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Daprodustat Formulations in Healthy Volunteers
NCT04640311Phase 1Completed
- Sponsor
- GSK
- Start
- Dec 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of daprodustat in anemia (5 arms), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Zero to Time of Last Quantifiable Concentration at 24 hours and Maximum Observed Plasma Concentration at 24 hours. Started Dec 2020; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04640311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04640311.